Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Cantor Fitzgerald Analyst Reiterates Overweight Rating on 89bio with 29 Price Target

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
Finance_Capitalistic
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

On March 4, 2024, analyst Kristen Kluska from Cantor Fitzgerald reiterated an optimistic “Overweight” rating on 89bio (NASDAQ: ETNB) with a price target of $29. This reaffirmation underscores a bullish perspective on the company’s performance and growth potential. Cantor Fitzgerald has continuously supported 89bio with an “Overweight” recommendation, demonstrating unwavering confidence in the stock’s outlook. Despite occasional adjustments to the price target, Cantor Fitzgerald’s consistent endorsement of an “Overweight” rating showcases a favorable view on 89bio’s future direction.

ETNB Stock Price Soars 11.09% on March 4, 2024: Bullish Momentum Signals Strong Performance

On March 4, 2024, ETNB stock showed strong performance as it saw a significant increase in its share price. ETNB is currently trading in the middle of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been performing relatively well compared to its historical performance.

The price of ETNB shares increased by $1.40 since the market last closed, representing a notable 11.09% rise. The stock opened at $16.63, which was $4.01 higher than its previous close. This opening price jump suggests that there was strong demand for ETNB shares at the start of the trading day.

Overall, the positive price momentum and significant increase in share price on March 4th indicate that investors were bullish on ETNB stock. Investors should conduct thorough research and consider their own risk tolerance before making investment decisions.

ETNB Stock Performance: A Closer Look at Financial Data and Profitability Challenges

On March 4, 2024, investors closely monitored the performance of ETNB stock as the company released its financial data. ETNB’s total revenue information was currently unavailable, leaving investors with limited insights into the company’s overall financial health. However, the net income figures provided shed some light on the company’s profitability.

ETNB reported a net income of -$142.19 million over the past year, showing a 39.37% decrease compared to the previous year. In the fourth quarter, the company’s net income was -$40.23 million, which represented a 0.0% change from the previous quarter. These figures indicate that ETNB has been facing challenges in maintaining its profitability over the past year.

In terms of earnings per share (EPS), ETNB reported a figure of -$2.00 for the past year, reflecting a 31.84% increase compared to the previous year. However, in the fourth quarter, the company’s EPS was -$0.50, marking a 9.61% decrease from the previous quarter. This mixed performance in EPS suggests that while there have been some improvements in profitability on a yearly basis, there are still some challenges to overcome in the short term.

Overall, the financial data released by ETNB on March 4, 2024, indicates a mixed performance in terms of profitability. Investors will need to closely monitor the company’s future financial reports to assess whether ETNB can overcome its challenges and drive sustainable growth in the long run.

Tags: ETNB
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Title Astrophysics Breakthrough Discovery of New Celestial Body Challenges Current Understanding of the Universe

Healthcare-and-IT

Amesite Partners with PACE to Revolutionize Healthcare Continuing Education

Market Sentiment Shifts Towards Tetra Tech NYSE TTEK

Recommended

Alphabet Stock

Alphabet Shares Face Regulatory Headwinds Despite Autonomous Driving Breakthrough

4 months ago
Dish Network Stock

Institutional Investors Show Diverging Views on Dish Network’s Future

7 months ago
Finance_ Trading ratings today (2)

Lakeland Financial Exceeds Expectations with Fourth Quarter Earnings

2 years ago
DeFi Technologies Stock

DeFi Technologies: Navigating Expansion Amidst Legal Headwinds

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Trending

BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

by Kennethcix
March 25, 2026
0

BioNano Genomics has wrapped up its fiscal year 2025, presenting a financial picture marked by significant operational...

Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds
  • Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts
  • Evolent Health Bets on AI Leadership Amid Share Price Decline

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com